Teleflex Awarded National Group Purchasing Agreements with Premier, Inc.
- Teleflex awarded three group purchasing agreements with Premier, Inc.
- The agreements aim to provide healthcare providers with solutions to optimize patient outcomes and improve care quality.
- None.
WAYNE, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded three group purchasing agreements with Premier, Inc. Effective August 1st, 2023, the new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products in the Laryngoscope Systems, Laryngeal Masks Airways, and Disposable Anesthesia Products categories.
“As a manufacturer of market leading Airway Management products,1 we are delighted to have been awarded these agreements with Premier to provide products that help clinicians deliver the care they expect in order to improve the health and quality of people’s lives,” said Kevin Robinson, President and General Manager, Anesthesia & Emergency Medicine at Teleflex.
Teleflex, through its Rüsch™ and LMA™ products, provides healthcare providers solutions to optimize patient outcomes by offering broad portfolios to meet every day airway needs. The group purchasing agreements include access to Rüsch™ and Sheridan™ endotracheal tubes, nasal and oral airways, and LMA™ supraglottic devices.
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,400 U.S. hospitals and 250,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Reference:
1.2022 IQVIA MDSA data.
Teleflex, the Teleflex logo, Arrow, Deknatel, LMA, Pilling, QuikClot, Rüsch, Sheridan, UroLift, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks or registered trademarks of their respective owners. © 2023 Teleflex Incorporated. All rights reserved. MC-009036
Contact:
Teleflex Incorporated:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
investors.teleflex.com
610-948-2836
FAQ
What did Teleflex announce?
What are the categories covered by the agreements?
Who is the President and General Manager of Anesthesia & Emergency Medicine at Teleflex?
